Significant Accounting Policies (Details) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Related Party Transactions | ||||
| cash equivalents | $ 0 | $ 0 | ||
| Credit losses relating to loan receivable | 0 | |||
| Liminatus Pharma, LLC | ||||
| Related Party Transactions | ||||
| cash equivalents | 0 | $ 0 | ||
| Credit losses relating to loan receivable | 0 | 0 | ||
| Provision for income tax | 0 | 0 | ||
| CEO | ||||
| Related Party Transactions | ||||
| Compensation expense | $ 37,500 | $ 37,500 | ||
| CEO | Liminatus Pharma, LLC | ||||
| Related Party Transactions | ||||
| Compensation expense | $ 200,000 | $ 200,000 | ||
| X | ||||||||||
- Definition Amount of allowance for credit loss on financing receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|